Side-by-side comparison of AI visibility scores, market position, and capabilities
New York global management consulting (founded 1926, private) at ~$16B 2024 revenue; 40% AI-related projects, QuantumBlack AI (350+ scientists), "State of AI 2025" thought leadership competing with BCG and Deloitte for C-suite AI strategy.
McKinsey & Company is a New York City-based global management consulting firm — privately held as a partnership — providing strategy, operations, technology, and organization consulting to CEOs and C-suites of the world's largest corporations, governments, and institutions through approximately 40,000 professionals across 130+ offices in 70+ countries and approximately $16 billion in estimated revenue in 2024. Founded in Chicago in 1926 by James O. McKinsey, a University of Chicago accounting professor, the firm's modern identity was shaped by Marvin Bower (who joined in 1933 and led the firm from 1950-1967, establishing the partnership model, professional ethics standards, and global expansion that define McKinsey today). Global Managing Partner Bob Sternfels (reelected to a second and final three-year term in February 2024) oversees the firm through a challenging period that includes reputation headwinds from its opioid consulting work and global scrutiny of consulting industry practices. McKinsey's service capabilities span traditional strategy consulting through McKinsey Digital (digital transformation, analytics), QuantumBlack (AI and machine learning, acquired 2015), and McKinsey Technology (CTO/CIO advisory, technology strategy) — with over 7,000 employees in digital and technology roles and approximately 40% of 2024 projects estimated to be AI-related. McKinsey's "State of AI in 2025" report found that organizations now mitigate an average of four AI-related risks (versus two in 2022) and that AI high performers (6% of survey respondents) attribute 5%+ EBIT improvement to AI, with AI agents increasingly deployed as virtual coworkers rather than passive research assistants.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.